Clinically important deterioration in patients with COPD: a post-hoc analysis of ETHOS
D. Singh (Manchester, United Kingdom), F. Martinez (New York, NY, United States), J. Hurst (London, United Kingdom), M. Han (Ann Arbor, MI, United States), P. Darken (Gaithersburg, MD, United States), M. Patel (Cambridge, United Kingdom)
Source: International Congress 2022 – COPD management: comorbidities, cohorts and real-world studies
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Singh (Manchester, United Kingdom), F. Martinez (New York, NY, United States), J. Hurst (London, United Kingdom), M. Han (Ann Arbor, MI, United States), P. Darken (Gaithersburg, MD, United States), M. Patel (Cambridge, United Kingdom). Clinically important deterioration in patients with COPD: a post-hoc analysis of ETHOS. 2104
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|